NCT05319743

Evaluating Quality and Value of US Ambulatory Care Delivered Among Medicaid Expansion/Non-Expansion States, 2012-2015

Completed Last updated 3 February 2023

What this trial tests

trial testing Medicaid Expansion in Medicaid Expansion in 200,000 participants. Completed in 1 May 2022.

Timeline

1 October 2021

Primary endpoint
1 May 2022

1 May 2022

Quick facts

Lead sponsor	University of California, Los Angeles
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200,000
Start date	1 October 2021
Primary completion	1 May 2022
Estimated completion	1 May 2022
Sites	1 location across United States

Drugs / interventions tested

• Medicaid Expansion

Conditions studied

• Medicaid Expansion — all drugs for Medicaid Expansion →

Sponsor

University of California, Los Angeles

Who can join

18 and older, any sex, with Medicaid Expansion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Quasi-experimental pre-post analysis of the rate of high-value and low-value care services between states that expanded Medicaid and states that did not expand Medicaid January 1, 2014, for adult ambulatory visits, using visit-level survey data from the National Ambulatory Medical Care Survey January 1, 2012 - December 31, 2015.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Evaluating the accessibility and value of U.S. ambulatory care among Medicaid expansion states and non-expansion states, 2012-2015.
   Parzuchowski A, Oronce C, Guo R, Tseng CH, et al · · 2023 · cited 3× · PMID 37400793 · DOI 10.1186/s12913-023-09696-x